Levra, S.; Guida, G.; Sprio, A.E.; Crosa, F.; Ghio, P.C.; Bertolini, F.; Carriero, V.; Albera, C.; Ricciardolo, F.L.M.
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience. Biomedicines 2022, 10, 3229.
https://doi.org/10.3390/biomedicines10123229
AMA Style
Levra S, Guida G, Sprio AE, Crosa F, Ghio PC, Bertolini F, Carriero V, Albera C, Ricciardolo FLM.
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience. Biomedicines. 2022; 10(12):3229.
https://doi.org/10.3390/biomedicines10123229
Chicago/Turabian Style
Levra, Stefano, Giuseppe Guida, Andrea Elio Sprio, Flavio Crosa, Paolo Carlo Ghio, Francesca Bertolini, Vitina Carriero, Carlo Albera, and Fabio Luigi Massimo Ricciardolo.
2022. "Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience" Biomedicines 10, no. 12: 3229.
https://doi.org/10.3390/biomedicines10123229
APA Style
Levra, S., Guida, G., Sprio, A. E., Crosa, F., Ghio, P. C., Bertolini, F., Carriero, V., Albera, C., & Ricciardolo, F. L. M.
(2022). Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience. Biomedicines, 10(12), 3229.
https://doi.org/10.3390/biomedicines10123229